Disorders of plasma lipid spectrum, lysoform levels of platelet activating factor and blood platelet sensitivity to adrenaline in patients with stable stress-induced stenocardia
Gereliuk, I.P.; Stukal, I.V.
Kardiologiia 31(1): 82-83
1991
ISSN/ISBN: 0022-9040 PMID: 2046258 Document Number: 371394
Document emailed within 1 workday
Related Documents
Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Floch, A.; Tahraoui, L.; Sedivy, P.; Cavero, I. 1991: The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes Journal of Pharmacology and Experimental Therapeutics 258(2): 567-575
Moreno, P.; Gijon, M.A.; Fradera, R.; Fabregat, J.; Rafecas, A.; Biondo, S.; Figueras, J.; Sánchez-Crespo, M.; Jaurrieta, E. 1993: Changes in peripheral blood levels of platelet-activating factor after orthotopic liver transplantation Transplantation Proceedings 25(4): 2642-2643
Ostermann, G.; Rühling, K.; Zabel-Langhennig, R.; Winkler, L.; Schlag, B.; Till, U. 1987: Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor Thrombosis Research 47(3): 279-285
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
Nakae, H.; Endo, S.; Inada, K.; Yaegashi, Y.; Takakuwa, T.; Yamada, Y.; Arakawa, N.; Suzuki, T.; Taniguchi, S.; Shimamura, T.; Ogawa, M.; Teraoka, H. 1996: Nitrite/nitrate (NOX) and type II phospholipase A2, leukotriene B4, and platelet-activating factor levels in patients with septic shock Research Communications in Molecular Pathology and Pharmacology 92(2): 131-139
Macpherson, J.L.; Kemp, A.; Rogers, M.; Mallet, A.I.; Toia, R.F.; Spur, B.; Earl, J.W.; Chesterman, C.N.; Krilis, S.A. 1989: Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis Clinical and Experimental Immunology 77(3): 391-396
Kawahara, Y.; Kariya, K.; Araki, S.; Fukuzaki, H.; Takai, Y. 1988: Platelet-derived growth factor (PDGF)-induced phospholipase C-mediated hydrolysis of phosphoinositides in vascular smooth muscle cells--different sensitivity of PDGF- and angiotensin II-induced phospholipase C reactions to protein kinase C-activating phorbol esters Biochemical and Biophysical Research Communications 156(2): 846-854
Mak, K.H.; Kottke-Marchant, K.; Brooks, L.M.; Topol, E.J. 1998: In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia Thrombosis and Haemostasis 80(6): 989-993
Barradas, M.A.; Stansby, G.; Hamilton, G.; Mikhailidis, D.P. 1994: Diminished platelet yield and enhanced platelet aggregability in platelet-rich plasma of peripheral vascular disease patients International Angiology: a Journal of the International Union of Angiology 13(3): 202-207
Nolte, D. 1989: Platelet activating factor produces platelet activating factor, comes to nothing Medizinische Klinik 84(6): 319-320
Ryan, K.L.; Jauchem, J.R.; Tehrany, M.R.; Boyle, H.L. 2002: Platelet-activating factor does not mediate circulatory failure induced by 35-GHz microwave heating Methods and Findings in Experimental and Clinical Pharmacology 24(5): 279-286
Peng, S-ying.; Zhang, F-ying.; Ou-Yang, X-yu.; Liu, Y.; Wang, W-jie. 2006: Effect of ginkgolide B on the platelet-activating factor induced changes of chemotaxis and cytoskeleton of macrophages Yao Xue Xue Bao 41(2): 156-160
Goodfield, M.J.; Orchard, M.A.; Rowell, N.R. 1988: Increased platelet sensitivity to collagen-induced aggregation in whole blood patients with systemic sclerosis Clinical and Experimental Rheumatology 6(3): 285-288
Lakin, K.M.; Kulikov, V.I.; Manevich, E.M.; Muliar, A.G.; Shvets, V.I. 1988: Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation Farmakologiia i Toksikologiia 51(4): 113-123
Cheng, D.; Chen, W.; Yang, X. 1996: The level of platelet activating factor in blood of rats with hypoxic pulmonary hypertension Hua Xi Yi Ke da Xue Xue Bao 27(2): 139-142
Carolan, E.J.; Casale, T.B. 1990: Degree of platelet activating factor-induced neutrophil migration is dependent upon the molecular species Journal of Immunology 145(8): 2561-2565
Coker, A.; Coker, I.; Huseyinov, A.; Sokmen, S.; Karademir, S. 2001: Is mannitol effective against platelet-activating factor (PAF)-induced liver damage in obstructive jaundice? Hepato-Gastroenterology 48(40): 1134-1137
Damas, J.; Prunescu, P. 1993: Presence of immunoreactive platelet-activating factor in peritoneal exudate induced by zymosan in rats Archives Internationales de Pharmacodynamie et de Therapie 322: 115-123